Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Assessing mean apnea-hypopnea duration (MAD) in patients with OSA yields hypoxemia and symptom burden data not provided by the AHI or ODI.

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

Intranasal saline is effective as a first-line treatment option before considering polysomnography or surgery.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...

TORONTO, ONTARIO, CANADA - 2014/04/12: Female wearing the CPAP mask for treating the sleep apnea which is a type of sleep disorder characterized by pauses in breathing or instances of shallow or ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Patients with obstructive sleep apnea appear to be at greater risk for kidney and bladder cancer. Obstructive sleep apnea is associated with a higher risk for kidney and bladder cancer, but not ...

Many people think that snoring is just a normal part of sleep. But for some, it can be a sign of a serious and often ignored ...